WELCOME TO The PHARMACEUTICAL REPORT
Cancer Drugs Bring in Most Pharma Revenue
February 25, 2020
I'm For Real
Enter your details once to access all our information and resources
Have you got the insight you need to stay at the forefront of today’s market developments.
Infographic | April 16, 2020
Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.
Infographic | April 6, 2020
Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.
Infographic | February 5, 2020
A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.
Infographic | March 12, 2022
Pharmaceutical industry and medicine vector infographics with drugs, pills, bottles and packages, text blocks and charts all around
Infographic | June 3, 2022
Pharma Technology Focus is free to read on all devices.
Infographic | May 20, 2022
This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE